Southeastern United States is witnessing an alarming uptick in cases of respiratory syncytial virus (RSV), a highly contagious respiratory illness that primarily affects children and older adults. The Centers for Disease Control and Prevention (CDC) has issued a warning, highlighting the unusual early emergence of RSV infections in the region, particularly in Florida and Georgia.
Early and Unprecedented RSV Surge
According to the recent report of ABC News, in September 07, 2023, the Centers for Disease Control and Prevention (CDC) issued a stark warning this week as respiratory syncytial virus (RSV) infections surged among young children in specific regions of the Southeastern United States. Typically, RSV season follows a predictable pattern, starting in the fall and extending through the winter, mirroring the patterns of the flu and other respiratory illnesses. However, this year has seen an unusual and concerning rise in RSV cases, particularly in Southeastern United States , Florida and Georgia. The CDC’s recent health advisory highlights the alarming trends in RSV positivity rates and hospitalizations, signaling a potential nationwide risk.
In the Southeastern United States, RSV is making an unexpected and concerning appearance well ahead of its usual season. Florida and Georgia are at the forefront of this unsettling trend. Recent data reveals that the three-week average of PCR test positivity for RSV in Florida has soared above 5%, surpassing the typical threshold of 3% observed at the onset of the RSV season.
Furthermore, in Georgia, RSV-related hospitalizations among children under the age of four have risen dramatically, climbing from 2.0 per 100,000 for the week ending August 5 to a worrisome 7.0 per 100,000 for the week ending August 19 in Southeastern United States . Of particular concern is the fact that a majority of these hospitalizations involve infants less than a year
READ ALSO: New Video Footage Reveals Chester County Prison Escapee’s Escape Method
Vulnerable Populations at Risk and Promising Interventions
In a report featured by CNN News, RSV poses a significant threat to certain demographics, including infants, young children, and older adults in Southeastern United States . The virus typically manifests with symptoms like fever, runny nose, coughing, and wheezing, which can escalate quickly, especially in susceptible individuals. Shockingly, between 100 and 300 children succumb to RSV annually, along with 6,000 to 10,000 senior citizens, according to the CDC. However, there is a glimmer of hope on the horizon this season.
For the first time ever, adults over 60 can receive RSV vaccinations, akin to flu shots, at major pharmacy chains such as CVS, Rite Aid, and Walgreens. Additionally, a new RSV drug named Beyfortus has gained approval for infants under eight months, offering a potential lifeline for high-risk infants, while a groundbreaking RSV immunization for pregnant women awaits CDC approval, aiming to provide crucial protection to newborns. These developments signal a promising shift in the fight against RSV, offering a ray of hope amid the current surge in cases in the Southeastern United States.